Whittier Trust Co. of Nevada Inc. Acquires New Holdings in The Clorox Company (NYSE:CLX)

Whittier Trust Co. of Nevada Inc. acquired a new stake in shares of The Clorox Company (NYSE:CLX) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 1,000 shares of the company’s stock, valued at approximately $153,000.

A number of other institutional investors also recently added to or reduced their stakes in the stock. Whittier Trust Co. boosted its position in Clorox by 11.7% during the first quarter. Whittier Trust Co. now owns 4,451 shares of the company’s stock valued at $681,000 after purchasing an additional 467 shares in the last quarter. FinTrust Capital Advisors LLC boosted its holdings in Clorox by 218.5% in the first quarter. FinTrust Capital Advisors LLC now owns 379 shares of the company’s stock worth $58,000 after acquiring an additional 260 shares in the last quarter. Daiwa Securities Group Inc. boosted its holdings in Clorox by 44.2% in the first quarter. Daiwa Securities Group Inc. now owns 16,505 shares of the company’s stock worth $2,527,000 after acquiring an additional 5,056 shares in the last quarter. Graypoint LLC boosted its holdings in Clorox by 123.0% in the first quarter. Graypoint LLC now owns 3,254 shares of the company’s stock worth $498,000 after acquiring an additional 1,795 shares in the last quarter. Finally, Nordea Investment Management AB boosted its holdings in Clorox by 4.5% in the first quarter. Nordea Investment Management AB now owns 9,977 shares of the company’s stock worth $1,519,000 after acquiring an additional 426 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on CLX. Morgan Stanley reissued an “equal weight” rating and issued a $160.00 price target on shares of Clorox in a report on Tuesday, March 26th. Jefferies Financial Group raised Clorox from an “underperform” rating to a “hold” rating and set a $145.00 price target for the company in a report on Tuesday, March 26th. Barclays lowered their price target on Clorox from $136.00 to $132.00 and set an “underweight” rating for the company in a report on Thursday, May 2nd. BNP Paribas assumed coverage on Clorox in a report on Monday, June 24th. They set an “underperform” rating and a $130.00 target price for the company. Finally, Wells Fargo & Company decreased their target price on Clorox from $140.00 to $135.00 and set an “underweight” rating for the company in a report on Thursday, May 2nd. Five investment analysts have rated the stock with a sell rating and fourteen have given a hold rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and an average price target of $145.33.

Clorox Stock Performance

CLX stock traded down $1.00 during trading on Tuesday, hitting $131.85. 1,109,086 shares of the company traded hands, compared to its average volume of 1,250,358. The company has a market cap of $16.37 billion, a PE ratio of 68.32, a P/E/G ratio of 1.98 and a beta of 0.39. The Clorox Company has a 1 year low of $114.68 and a 1 year high of $169.14. The stock’s 50-day simple moving average is $135.29 and its 200 day simple moving average is $143.42. The company has a debt-to-equity ratio of 9.73, a current ratio of 0.90 and a quick ratio of 0.53.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Tuesday, April 30th. The company reported $1.71 EPS for the quarter, beating analysts’ consensus estimates of $1.33 by $0.38. The business had revenue of $1.81 billion during the quarter, compared to analysts’ expectations of $1.87 billion. Clorox had a return on equity of 302.49% and a net margin of 3.33%. The business’s revenue was down 5.3% compared to the same quarter last year. During the same period in the previous year, the business earned $1.51 earnings per share. On average, equities analysts expect that The Clorox Company will post 5.91 earnings per share for the current fiscal year.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.